Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients
Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins ‘America’s Newsroom’ to explain.
x
Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients
Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins ‘America’s Newsroom’ to explain.